Repotrectinib is a tyrosine kinase inhibitor compound used as a pharmaceutical raw material. It is designed for the manufacturing of therapies targeting ROS1-positive non-small cell lung cancer.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Repotrectinib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Selitrectinib
pharmaceutical raw material
IDRX-42
pharmaceutical raw material
Crenolanib
pharmaceutical raw material
Neratinib
pharmaceutical raw material
Ferric pyrophosphate citrate
pharmaceutical raw material
Milvexian
pharmaceutical raw material
Filgotinib maleate
pharmaceutical raw material
Clazosentan
pharmaceutical raw material
The international HS code for Repotrectinib (CAS 1802220-02-5) is 2934.99.
2934.99
2934 99 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
(3R,11S)-6-fluoro-3,11-dimethyl-10-oxa-2,13,17,18,21-pentazatetracyclo[13.5.2.04,9.018,22]docosa-1(21),4(9),5,7,15(22),16,19-heptaen-14-one
FIKPXCOQUIZNHB-WDEREUQCSA-N
C[C@H]1CNC(=O)C2=C3N=C(C=CN3N=C2)N[C@@H](C4=C(O1)C=CC(=C4)F)C
Sourcing Repotrectinib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.